{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:24:19Z","timestamp":1778631859093,"version":"3.51.4"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":4079,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"Marato Fundaci\u00f3 TV3","award":["U-2000-TV2710"],"award-info":[{"award-number":["U-2000-TV2710"]}]},{"name":"Fondo de Investigaciones Sanitarias de la Seguridad Social","award":["FISS 02\/0701"],"award-info":[{"award-number":["FISS 02\/0701"]}]},{"name":"Direcci\u00f3n General de Investigaci\u00f3n Cient\u00edf\u00edco y T\u00e9cnica","award":["SAF 2001\/0300"],"award-info":[{"award-number":["SAF 2001\/0300"]}]},{"name":"Instituto Reina Sof\u00eda de Investigaci\u00f3n Nefrol\u00f3gica, and Instituto de Salud Carlos III","award":["C03\/2"],"award-info":[{"award-number":["C03\/2"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1002\/hep.20313","type":"journal-article","created":{"date-parts":[[2004,6,30]],"date-time":"2004-06-30T21:32:29Z","timestamp":1088631149000},"page":"16-18","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["Management of hepatorenal syndrome: Another piece of the puzzle\u2020"],"prefix":"10.1097","volume":"40","author":[{"given":"Pere","family":"Gin\u00e8s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica","family":"Guevara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Perez-Villa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-6-20241201","doi-asserted-by":"crossref","first-page":"18191827","DOI":"10.1016\/S0140-6736(03)14903-3","article-title":"Hepatorenal syndrome.","volume":"362","author":"Gines","year":"2003","journal-title":"Lancet"},{"key":"R2-6-20241201","doi-asserted-by":"crossref","first-page":"729737","DOI":"10.1136\/gut.49.5.729","article-title":"The hepatorenal syndrome.","volume":"49","author":"Dagher","year":"2001","journal-title":"Gut"},{"key":"R3-6-20241201","doi-asserted-by":"crossref","first-page":"393400","DOI":"10.1053\/jhep.2003.50084","article-title":"Acute renal failure in patients with cirrhosis. Perspectives in the age of MELD.","volume":"37","author":"Moreau","year":"2003","journal-title":"HEPATOLOGY"},{"key":"R4-6-20241201","first-page":"11211125","article-title":"Electrolyte and circulatory changes in terminal liver failure.","volume":"271","author":"Hecker","year":"1956","journal-title":"Lancet"},{"key":"R5-6-20241201","first-page":"504510","article-title":"Renal and intrarenal blood-flow in cirrhosis of the liver.","volume":"2","author":"Kew","year":"1971","journal-title":"Lancet"},{"key":"R6-6-20241201","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis.","volume":"8","author":"Schrier","year":"1988","journal-title":"HEPATOLOGY"},{"issue":"Suppl","key":"R7-6-20241201","first-page":"S6989","article-title":"Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management.","volume":"38","author":"Arroyo","year":"2003","journal-title":"J Hepatol"},{"key":"R8-6-20241201","first-page":"315320","article-title":"Milestones on liver disease. A commentary on Hecher R, Sherlock S. Electrolyte and circulatory changes in terminal liver failure.","volume":"36","author":"Arroyo","year":"2002","journal-title":"J Hepatol"},{"key":"R9-6-20241201","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1002\/hep.510270107","article-title":"Jimenez Wet et al. Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion.","volume":"27","author":"Guevara","year":"1998","journal-title":"HEPATOLOGY"},{"key":"R10-6-20241201","doi-asserted-by":"crossref","first-page":"56570","DOI":"10.1016\/S0168-8278(98)80151-7","article-title":"Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome.","volume":"29","author":"Hadengue","year":"1998","journal-title":"J Hepatol"},{"key":"R11-6-20241201","doi-asserted-by":"crossref","first-page":"870875","DOI":"10.1002\/hep.510300430","article-title":"Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine.","volume":"30","author":"Gulberg","year":"1999","journal-title":"HEPATOLOGY"},{"key":"R12-6-20241201","doi-asserted-by":"crossref","first-page":"4348","DOI":"10.1016\/S0168-8278(00)80158-0","article-title":"Sort P, Jimenez W, Salieron JM, et al. Terlipressin plus albumin infusion is an effective and safe therapy of hepatorenal syndrome.","volume":"33","author":"Uriz","year":"2000","journal-title":"J Hepatol"},{"key":"R13-6-20241201","first-page":"1519","article-title":"Long-term terlipressin administration improves renal function in cirrhotic patients with type 1 hepatorenal syndrome: a pilot study.","volume":"64","author":"Mulkay","year":"2001","journal-title":"Acta Gastroenterol Belg"},{"key":"R14-6-20241201","doi-asserted-by":"crossref","first-page":"923930","DOI":"10.1053\/gast.2002.32364","article-title":"Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: A restrospective multicenter study.","volume":"122","author":"Moreau","year":"2002","journal-title":"Gastroenterology"},{"key":"R15-6-20241201","doi-asserted-by":"crossref","first-page":"941948","DOI":"10.1053\/jhep.2002.35819","article-title":"Terlipressin therapy with and without albumin for patients with hepatorenal syndrome. Results of a prospective, non-randomized study.","volume":"36","author":"Ortega","year":"2002","journal-title":"HEPATOLOGY"},{"key":"R16-6-20241201","doi-asserted-by":"crossref","first-page":"16901697","DOI":"10.1002\/hep.510290629","article-title":"Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide.","volume":"29","author":"Angeli","year":"1999","journal-title":"HEPATOLOGY"},{"key":"R17-6-20241201","doi-asserted-by":"crossref","first-page":"374380","DOI":"10.1053\/jhep.2002.34343","article-title":"Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study.","volume":"36","author":"Duvoux","year":"2002","journal-title":"HEPATOLOGY"},{"key":"R18-6-20241201","doi-asserted-by":"crossref","first-page":"5564","DOI":"10.1002\/hep.20262","article-title":"Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.","volume":"40","author":"Wong","year":"2004","journal-title":"HEPATOLOGY"},{"key":"R19-6-20241201","doi-asserted-by":"crossref","first-page":"416422","DOI":"10.1002\/hep.510280219","article-title":"Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems.","volume":"28","author":"Guevara","year":"1998","journal-title":"HEPATOLOGY"},{"key":"R20-6-20241201","first-page":"R390394","article-title":"Reflex effects of hepatic baroreceptors on renal and cardiac sympathetic nerve activity.","volume":"238","author":"Kostreva","year":"1980","journal-title":"Am J Physiol"},{"key":"R21-6-20241201","first-page":"600608","article-title":"Cirrhotic cardiomyopathy: getting to the heart of the matter.","volume":"14","author":"Ma","year":"1996","journal-title":"HEPATOLOGY"},{"key":"R22-6-20241201","doi-asserted-by":"crossref","first-page":"259267","DOI":"10.1042\/cs0970259","article-title":"Role or cardiac structural and functional abnormalities in the pathogenesis of hyperdynamic circulation and renal sodium retention in cirrhosis.","volume":"97","author":"Wong","year":"1999","journal-title":"Clin Sci"},{"key":"R23-6-20241201","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1136\/heart.87.1.9","article-title":"Cirrhotic cardiomyopathy.","volume":"87","author":"Moller","year":"2002","journal-title":"Heart"},{"key":"R24-6-20241201","doi-asserted-by":"crossref","first-page":"13921394","DOI":"10.1136\/gut.52.10.1392","article-title":"Origins of cardiac dysfunction in cirrhosis.","volume":"52","author":"Jimenez","year":"2003","journal-title":"Gut"},{"key":"R25-6-20241201","doi-asserted-by":"crossref","first-page":"12101218","DOI":"10.1053\/jhep.2003.50447","article-title":"Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis.","volume":"38","author":"Ruiz-del-Arbol","year":"2003","journal-title":"HEPATOLOGY"},{"key":"R26-6-20241201","doi-asserted-by":"crossref","first-page":"10891091","DOI":"10.1053\/jhep.2003.50489","article-title":"Cardiac dysfunction in spontaneous bacterial peritonitis: a manifestation of cirrhotic cardiomyopathy.","volume":"38","author":"Lee","year":"2003","journal-title":"HEPATOLOGY"},{"key":"R27-6-20241201","doi-asserted-by":"crossref","first-page":"142148","DOI":"10.1111\/j.1572-0241.2002.05438.x","article-title":"Masini A, Efrati C, et al. Modifications of cardiac function in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt (TIPS).","volume":"97","author":"Merli","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"R28-6-20241201","doi-asserted-by":"crossref","first-page":"13701377","DOI":"10.1016\/j.hep.2003.09.030","article-title":"Humoral and cardiac effects of TIPS in cirrhotic patients with different effective blood volume.","volume":"38","author":"Salerno","year":"2003","journal-title":"HEPATOLOGY"},{"key":"R29-6-20241201","doi-asserted-by":"crossref","first-page":"403409","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.","volume":"341","author":"Sort","year":"1999","journal-title":"N Engl J Med"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.20313","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200407000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T12:00:13Z","timestamp":1733054413000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200407000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.20313","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}